CA2027814A1 - Traitement d'une maladie hepatobiliaire a base de composes 5-cetoprostaglandin - Google Patents

Traitement d'une maladie hepatobiliaire a base de composes 5-cetoprostaglandin

Info

Publication number: CA2027814A1
Authority: CA; Canada
Prior art keywords: treatment; keto; hepatobiliary disease; prostaglandin compounds; hepatobiliary
Prior art date: 1989-10-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA2027814A

Other languages

English (en)

Other versions

CA2027814C (fr

Inventor

Ryuji Ueno

Hiroyoshi Osama

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sucampo GmbH

Original Assignee

Ueno Seiyaku Oyo Kenkyujo KK

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-10-20

Filing date

1990-10-17

Publication date

1991-04-21

1990-10-17 Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK

1991-04-21 Publication of CA2027814A1 publication Critical patent/CA2027814A1/fr

1996-07-30 Application granted granted Critical

1996-07-30 Publication of CA2027814C publication Critical patent/CA2027814C/fr

2010-10-17 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CA002027814A 1989-10-20 1990-10-17 Traitement d'une maladie hepatobiliaire a base de composes 5-cetoprostaglandin Expired - Lifetime CA2027814C (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP27460689		1989-10-20
JP274606/1989		1989-10-20

Publications (2)

Publication Number	Publication Date
CA2027814A1 true CA2027814A1 (fr)	1991-04-21
CA2027814C CA2027814C (fr)	1996-07-30

Family

ID=17544076

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002027814A Expired - Lifetime CA2027814C (fr)	1989-10-20	1990-10-17	Traitement d'une maladie hepatobiliaire a base de composes 5-cetoprostaglandin

Country Status (10)

Country	Link
US (1)	US5096927A (fr)
EP (1)	EP0424156B1 (fr)
JP (1)	JPH03204816A (fr)
KR (1)	KR0127297B1 (fr)
AT (1)	ATE132749T1 (fr)
CA (1)	CA2027814C (fr)
DE (1)	DE69024744T2 (fr)
DK (1)	DK0424156T3 (fr)
ES (1)	ES2085898T3 (fr)
GR (1)	GR3018674T3 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE174221T1 (de) *	1990-05-01	1998-12-15	R Tech Ueno Ltd	Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
CA2150287C (fr)	1994-06-03	2004-08-10	Ryuji Ueno	Agent therapeutique pour les affections hepatobiliaires
CA2274670C (fr) *	1997-10-13	2011-04-12	R-Tech Ueno, Ltd.	15-ceto prostaglandines en tant qu'inhibiteurs de l'hypertension portale
AU739343B2 (en) *	1997-11-28	2001-10-11	Sucampo Ag	Endothelin antagonist
TWI225398B (en) *	1999-07-14	2004-12-21	R Tech Ueno Ltd	Composition for treatment of external secretion disorders
CN1241570C (zh) *	2000-04-06	2006-02-15	苏坎波公司	胆汁分泌促进组合物
TWI302100B (en) *	2001-05-02	2008-10-21	Sucampo Ag	Composition for treating drug-induced constipation
AR037524A1 (es) *	2001-11-14	2004-11-17	Sucampo Ag	Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en)	2001-11-19	2010-06-08	Sucampo Ag	Method for treating a disease or condition responsive to opening of C1C-2 channel
US20080207759A1 (en) *	2007-02-27	2008-08-28	Sucampo Ag	Method for protecting mitochondria
US20090082442A1 (en) *	2007-09-26	2009-03-26	Protia, Llc	Deuterium-enriched lubiprostone

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4374856A (en) *	1980-09-10	1983-02-22	The Upjohn Company	Liver cytoprotection using PGE's
FR2517679A1 (fr) *	1981-12-03	1983-06-10	Synthelabo	Derives de diaza-3,7a cyclohepta (j,k) fluorenes, leur preparation et leur application en therapeutique
JPS58164512A (ja) *	1982-03-25	1983-09-29	Ono Pharmaceut Co Ltd	プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
DE3401542A1 (de) *	1984-01-18	1985-08-01	Merck Patent Gmbh, 6100 Darmstadt	Schwefelhaltige 6-ketoprostaglandine
EP0153858A3 (fr) *	1984-02-29	1985-12-11	The Upjohn Company	Application thérapeutique de prostaglandines
JPS62277352A (ja) *	1986-01-30	1987-12-02	Ono Pharmaceut Co Ltd	新規な６−ケト−プロスタグランジンｅ１誘導体、それらの製造方法およびそれらを有効成分として含有する細胞障害治療剤
CA1323364C (fr) *	1987-01-28	1993-10-19	Ryuzo Ueno	Prostaglandines e et agents anti-ulcereux contenant celles-ci
CA1322749C (fr) *	1987-01-28	1993-10-05	Ryuzo Ueno	Prostaglandines de la serie d, et tranquilisants et soporifiques en contenant
CA1324129C (fr) *	1987-04-30	1993-11-09	Ryuzo Ueno	Prostaglandines de la serie f
DE3869471D1 (de) *	1987-05-15	1992-04-30	Ueno Seiyaku Oyo Kenkyujo Kk	Fiebersteigende zusammensetzung.
DE3876050T2 (de) *	1987-09-18	1993-03-25	Ueno Seiyaku Oyo Kenkyujo Kk	Okulare hypotensivagenzien.
GB2210556B (en) *	1987-10-02	1991-07-17	Ueno Seiyaku Oyo Kenkyujo Kk	The use of 15-keto-16-halo-prostaglandins in cathartic compositions
JP2597629B2 (ja) *	1988-02-26	1997-04-09	株式会社上野製薬応用研究所	１３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
JP2597649B2 (ja) *	1988-05-11	1997-04-09	株式会社上野製薬応用研究所	気管・気管支拡張剤
AU619543B2 (en) *	1988-05-11	1992-01-30	Sucampo Ag	Use of 15-ketoprostaglandin e or f compounds for uterine contraction
JPH03101622A (ja) *	1989-09-11	1991-04-26	Green Cross Corp:The	肝炎予防治療剤

1990
- 1990-10-17 CA CA002027814A patent/CA2027814C/fr not_active Expired - Lifetime
- 1990-10-18 EP EP90311457A patent/EP0424156B1/fr not_active Expired - Lifetime
- 1990-10-18 AT AT90311457T patent/ATE132749T1/de not_active IP Right Cessation
- 1990-10-18 DE DE69024744T patent/DE69024744T2/de not_active Expired - Lifetime
- 1990-10-18 DK DK90311457.7T patent/DK0424156T3/da active
- 1990-10-18 ES ES90311457T patent/ES2085898T3/es not_active Expired - Lifetime
- 1990-10-19 US US07/600,048 patent/US5096927A/en not_active Expired - Lifetime
- 1990-10-19 JP JP2282420A patent/JPH03204816A/ja active Granted
- 1990-10-20 KR KR1019900016811A patent/KR0127297B1/ko not_active IP Right Cessation
1996
- 1996-01-16 GR GR960400072T patent/GR3018674T3/el unknown

Also Published As

Publication number	Publication date
CA2027814C (fr)	1996-07-30
ATE132749T1 (de)	1996-01-15
KR910007531A (ko)	1991-05-30
ES2085898T3 (es)	1996-06-16
EP0424156A3 (en)	1992-04-22
DK0424156T3 (da)	1996-02-05
US5096927A (en)	1992-03-17
EP0424156A2 (fr)	1991-04-24
EP0424156B1 (fr)	1996-01-10
GR3018674T3 (en)	1996-04-30
DE69024744D1 (de)	1996-02-22
JPH0571568B2 (fr)	1993-10-07
DE69024744T2 (de)	1996-05-23
KR0127297B1 (ko)	1998-04-01
JPH03204816A (ja)	1991-09-06

Similar Documents

Publication	Publication Date	Title
CA2150251A1 (fr)	1994-11-10	Lyospheres contenant de la gonadotropine
MX9602683A (es)	1997-06-28	Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
CA2041417A1 (fr)	1991-11-02	Traitement d'une maladie du pancreas a l'aide de composes de 15-ceto-prostaglandine
AU2710892A (en)	1993-04-29	Cytotoxic bicyclo (7.3.1) tridec-4-ene-2,6-diyne compounds and process for the preparation thereof
CA2046069A1 (fr)	1992-01-11	Traitement des maladies inflammatoires au moyen de composes de 15-cetoprostaglandine
AU631169B2 (en)	1992-11-19	Thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
DE69631609D1 (en)	2004-03-25	Tricyclische erythromycinderivate
CA2062653A1 (fr)	1992-09-15	Promotion de la cicatrisation avec des composes a base de 15-cetoprostaglandine
AU625083B2 (en)	1992-07-02	Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)- en-20-yn-3-one
CA2027814A1 (fr)	1991-04-21	Traitement d'une maladie hepatobiliaire a base de composes 5-cetoprostaglandin
AU5059690A (en)	1990-09-06	(3-(c16-c18)-alkanesulphinyl- and sulphonyl-2-methoxy-methyl-propyl)-(2-trimethylammonioethyl) phosphates, processes for the preparation thereof and pharmaceutical compositions containing them
AU2837089A (en)	1989-07-20	New indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
CA2042934A1 (fr)	1991-11-23	Traitement de l'hypertension oculaire au moyen d'une combinaison synergique oculaire
CA2114859A1 (fr)	1994-08-04	Compose cytotoxique et antiviral
CA2042937A1 (fr)	1991-11-23	Traitement de l'hypertension oculaire au moyen d'une combinaison synergique
CA2030344A1 (fr)	1991-05-23	Traitement de troubles pulmonaires a l'aide de composes de 15-ceto-prostaglandines
HUT50787A (en)	1990-03-28	Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
CA2041240A1 (fr)	1991-10-28	Traitement biochimique a l'aide de 15-deshydroxy-16-oxoprostaglandine
AU5992990A (en)	1991-01-31	14,17alpha-etheno- and -ethanoestratrienes, processes for the preparation of these compounds, as well as their use for the production of medicinal agents
CA2048245A1 (fr)	1992-02-03	Traitement de la cataracte avec des composes a base de prostacycline
CA2042936A1 (fr)	1991-11-23	Traitement de l'hypertension oculaire au moyen d'une combinaison synergique pour utilisation ophtalmique
IL110780A0 (en)	1994-11-11	Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
CA2057456A1 (fr)	1992-07-05	Produit pharmaceutique contre la depression
CA2292017A1 (fr)	2000-06-14	Cycloheptenes substitues, leur preparation et utilisation
CA2022081A1 (fr)	1991-01-28	Traitement de l'hyperlipidemie a l'aide de composes de 15-ceto-prostaglandine

Legal Events

Date	Code	Title	Description
1994-03-28	EEER	Examination request
2010-10-17	MKEX	Expiry